Novo Nordisk

NVO | NYSE | 386 Followers

$58.20

+1.75%

$1.00

Overview Metrics Financials

Fair Price

$72.15

Undervalued by 23.6%

To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Novo Nordisk A/S (NVO) is a Danish pharmaceutical company specializing in the development, manufacturing, and sale of medicines for the treatment of diabetes and other endocrine and metabolic disorders. The company is one of the world's leading manufacturers of insulin and insulin-related medications, which are essential for diabetes treatment. Novo Nordisk also offers other pharmaceutical products for the treatment of obesity, hemophilia, and various endocrine disorders. The company emphasizes on research and innovation in the field of diabetes and other endocrine diseases and has long been committed to fighting diabetes and obesity. Novo Nordisk A/S has extensive international operations, and its products are available in more than 170 countries. Shares of Novo Nordisk A/S (NVO) could represent an intriguing investment opportunity for those who believe in the long-term demand for diabetes and metabolic medications.

Feed

Bill Combs

@billcombs

>2y

Novo Nordisk A/S is a Danish company that recently introduced a cure for obesity. Shares of $NVO are up more than 20% in the past month and more than 40% this year. For me, the company is going in a good direction and the business is also great, as obesity is really affecting a lot of people at the moment and if the development of this drug goes as well in the future as it has...
Read more

Zobrazit další komentáře

Ashraf Aboudar

@ashraf_dd >2y

The company is doing very well indeed. It's healthy and making solid amounts of money. The chart is logically consistent with that. But now I think it's way up and even though there's no major tooth on the chart, I'm not going to go for it.

Like 0 1

Jason Bellier

@neostonks

>2y

Novo Nordisk $NVO closed the day yesterday with a larger market capitalisation than LVMH, making it Europe's largest public company. Novo's share price rose 1.9 percent to $189.3, giving the company a market capitalization of $423 billion.

Do you have shares of $NVO in your portfolio?

Zobrazit další komentáře

Bill Combs

@billcombs >2y

I don't have NVO stock in my portfolio, but I am very interested in the company and have been following it from afar :)

Like 0

Daniela Duong

@danieladuong

>2y

Have a nice Sunday, what are your views on Novo Nordisk $NVO farm ? Thursday's results were very good and the company is obviously doing very well right now :)